报价延迟最少15分钟:2025/01/21 08:54 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-4.99/-0.70
|
|
企业价值
35.33M
|
| 资产负债 |
|
每股账面净值
1.30
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
13.80M
|
|
每股收益
2.62
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/01/21 08:54 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues. |